Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

Bigot, Pierre

Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? [electronic resource] - World journal of urology Feb 2014 - 109-14 p. digital

Publication Type: Journal Article; Multicenter Study

1433-8726

10.1007/s00345-013-1088-1 doi


Adult
Aged
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--epidemiology
Combined Modality Therapy
Comorbidity
Dose-Response Relationship, Drug
Female
France
Humans
Indoles--therapeutic use
Kidney Neoplasms--epidemiology
Male
Middle Aged
Molecular Targeted Therapy
Neoadjuvant Therapy
Nephrectomy
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Pyrroles--therapeutic use
Retrospective Studies
Sorafenib
Sunitinib
Thrombectomy
Thrombosis--epidemiology
Treatment Outcome
Vena Cava, Inferior--surgery